Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine
Genetics: Expression signature identifies high-risk patients A gene expression signature identifies breast cancer patients who do poorly after endocrine therapy and might benefit from extra treatment. A team led by John Bartlett and Paul Boutros from the Ontario Institute for Cancer Research in Toro...
Enregistré dans:
Auteurs principaux: | Jane Bayani, Cindy Q. Yao, Mary Anne Quintayo, Fu Yan, Syed Haider, Alister D’Costa, Cassandra L. Brookes, Cornelis J. H. van de Velde, Annette Hasenburg, Dirk G. Kieback, Christos Markopoulos, Luc Dirix, Caroline Seynaeve, Daniel Rea, Paul C. Boutros, John M. S. Bartlett |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e8e3e37c9ac342eb853c51e4f6f7efcc |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study
par: John M. S. Bartlett, et autres
Publié: (2021) -
Pathway-based subnetworks enable cross-disease biomarker discovery
par: Syed Haider, et autres
Publié: (2018) -
Stratified coastal ocean interactions with tropical cyclones
par: S. M. Glenn, et autres
Publié: (2016) -
Using nuclear receptor activity to stratify hepatocarcinogens.
par: Imran Shah, et autres
Publié: (2011) -
On-chip spectrometers using stratified waveguide filters
par: Ang Li, et autres
Publié: (2021)